SOURCE: Signal Advance, Inc.

Signal Advance, Inc.

September 26, 2014 08:15 ET

Signal Advance, Inc. Announces Full DTC Eligibility

HOUSTON, TX--(Marketwired - Sep 26, 2014) - Signal Advance, Inc. (OTCBB: SIGL) (OTC Pink: SIGL) (PINKSHEETS: SIGL), a registered and fully reporting public US company, announced today that its common stock has been granted full eligibility by the Depository Trust Company (DTC), a subsidiary of the Depository Trust & Clearing Corporation (DTCC). DTC is the world's largest post-trade financial services company. It provides electronic clearance, settlement, and information services for the vast majority of the equities and other securities in the U.S. Trading of securities through DTC allows for cost-effective clearing and guaranteed settlement. Securities that are not DTC-eligible are often not accepted for trading at many brokerages due to the amount of paperwork and manpower required to execute and settle trades, thus making it more difficult for a significant percentage of investors to access the shares. DTC eligibility allows ownership of the company's shares to be transferred electronically by the DTC.

"We are pleased to have obtained full DTC eligibility which, we anticipate, will facilitate the process of trading and exchanging our common stock. This is the latest step in our efforts to increase the liquidity of our common stock and enhance shareholder value," said Chris M. Hymel, Ph.D., Founder, President and CEO of Signal Advance, Inc.

Signal Advance (SA) has developed and patented technology which temporally advances "real-world" analog signals representing physical properties such as pressure, flow, position, vibration, temperature, pressure, proximity, bioelectric activity (EKG, EEG, etc.). Prototype SA circuit designs for the time advance of bioelectric and other analog signals were tested in a University doctorate study completed in 2010. The study results were later published in a peer-reviewed, feature article in the IEEE Circuits and Systems Magazine (2011). The Company was awarded First Place in the 2011 Goradia Innovation Prize competition. In addition, Dr. Hymel was named the 2012 Innovator of the Year by the Intellectual Property Section of the Oklahoma Bar Association for his work related to the development of the company's proprietary SA technology. 

By temporally advancing signal detection, SA technology can potentially offset signal detection and processing delays, thereby, reducing response time and improving performance. Faster detection and response to abnormal medical, control, and/or alarm signals may enable more effective control or intervention in products and devices in dozens of markets such as medical (cardiac rhythm management, imaging, neurostimulation, radiotherapy), industrial (process control/ manufacturing), transportation (engine control, safety, Energy (generation, distribution) and defense (weaponry, targeting). The benefits which the marketplace and, ultimately, end-users may anticipate include improved outcomes in medicine, lower energy costs, enhanced efficiency, lower emissions, increased yields, as well as other financial benefits and product efficiency throughout a broad range of industrial applications.

For more information, visit www.signaladvance.com.

Forward-Looking Statements:
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks, including those set forth in the Company's Form 10-K filed with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and the Company undertakes no obligation to update such statements.

Contact Information